Filing of Scheme under Regulation 37(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements ) Regulations,2015("SEBI Listing Regulations")
NURECA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Nureca Limited has formally filed its Scheme of Merger by Absorption with BSE and NSE under Regulation 37(6) of the SEBI Listing Regulations. The scheme seeks to merge Nureca Technologies Private Limited (NTPL), its wholly owned subsidiary, into Nureca Limited (the listed parent company). The Board had already approved the draft scheme on May 20, 2025, with the Appointed Date set as April 1, 2025. Both companies are engaged in manufacturing health and wellness products, so the merger aims to consolidate operations, reduce overheads, simplify the group structure, and maximize shareholder value. Since NTPL is 100% owned by Nureca, no share exchange ratio applies — the subsidiary's shares will simply be cancelled upon dissolution. Because it is a wholly-owned subsidiary merger, no separate stock exchange 'No Objection Letter' is needed, though the scheme documents have been submitted for public dissemination on the exchange websites.
This is a routine internal restructuring with no change in shareholding pattern or control of the listed company, so existing shareholders will not be affected in terms of ownership or share count. The merger may marginally improve operational efficiency and reduce compliance costs, but is unlikely to have any material impact on stock price in the short term.